A 10mg vial of NAD+ (Nicotinamide Adenine Dinucleotide) contains a precise, lyophilized mass of the essential pyridine nucleotide coenzyme formulated for targeted in vitro assays and small-scale laboratory experiments. Principal investigators select the 10mg specification when running pilot enzymatic studies, assay calibration curves, or micro-volume cell culture treatments where minimizing freeze-thaw degradation is paramount. Below is the technical overview of molecular specifications, diluent mathematics, handling protocols, and verification standards for research-grade NAD+.
A 10mg vial of NAD+ (Nicotinamide Adenine Dinucleotide) contains a precise, lyophilized mass of the essential pyridine nucleotide coenzyme formulated for targeted in vitro assays and small-scale laboratory experiments. Principal investigators select the 10mg specification when running pilot enzymatic studies, assay calibration curves, or micro-volume cell culture treatments where minimizing freeze-thaw degradation is paramount. Below is the technical overview of molecular specifications, diluent mathematics, handling protocols, and verification standards for research-grade NAD+.
A 10mg NAD+ vial delivers exactly ten milligrams of pure, non-pyrogenic Nicotinamide Adenine Dinucleotide in a stable, lyophilized cake or powder matrix. As a central coenzyme found in all living cells, NAD+ serves as a critical electron acceptor in glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative phosphorylation, while also functioning as a substrate for NAD+-consuming enzymes such as sirtuins (SIRT1–7) and poly(ADP-ribose) polymerases (PARPs). In a laboratory setting, this specific vial mass is engineered to provide precise micro-molar concentrations without requiring extensive aliquot management or risk of compound wastage.
Investigators often choose the 10mg format for preliminary screening assays, baseline enzyme kinetics, or low-throughput cell culture models where fresh reconstitution is necessary to eliminate hydrolysis product accumulation. Please note: PX1 Research maintains flexible catalog configurations for our supply of high-purity NAD+. If the 10mg standalone fill size is currently out of stock or designated as a custom lot, researchers are encouraged to explore our full directory at /all-peptides to access equivalent multi-vial options or larger mass specifications such as 100mg and 500mg, which can be subdivided during preparation.
Nicotinamide Adenine Dinucleotide exists in two functional redox forms: the oxidized state ($NAD^+$) and the reduced state ($NADH$). The 10mg vial specification contains the oxidized dinucleotide form, defined by the chemical formula $C_{21}H_{27}N_{7}O_{14}P_{2}$ and a molecular weight of 663.43 g/mol. The molecule comprises two mononucleotides—nicotinamide mononucleotide and adenosine mononucleotide—joined by a phosphoanhydride linkage.
In preclinical and in vitro research, $NAD^+$ acts as an obligatory cofactor for dehydrogenases, facilitating energy transduction via reversible hydride transfer. Beyond redox balance, $NAD^+$ regulates chromatin remodeling, DNA repair mechanisms, and calcium signaling cascades via cyclic ADP-ribose synthesis. Achieving high chemical purity (>98%) is vital for these research applications, as trace organic impurities or degradation products like free nicotinamide can act as potent end-product inhibitors in sirtuin and PARP enzymatic assays.
Reconstitution calculations must be performed with precision to maintain target working concentrations in laboratory protocols. The final concentration ($C$) of the solution is governed by the standard volumetric equation $C = m / V$, where $m$ represents the lyophilized mass (10mg) and $V$ represents the volume of sterile diluent added.
Depending on the specific assay parameters, researchers typically employ biological-grade solvents such as sterile bacteriostatic water, phosphate-buffered saline (PBS, pH 7.4), or sterile nuclease-free water. The following concentration outputs correspond to standard diluent additions for a 10mg vial:
• 1.0 mL Diluent Addition: Yields a final concentration of 10.0 mg/mL (10.0 µg/µL, equivalent to ~15.07 mM). • 2.0 mL Diluent Addition: Yields a final concentration of 5.0 mg/mL (5.0 µg/µL, equivalent to ~7.54 mM). • 3.0 mL Diluent Addition: Yields a final concentration of 3.33 mg/mL (3.33 µg/µL, equivalent to ~5.02 mM).
For custom concentration protocols, working micro-molar conversions, or multi-vial volumetric scaling, lab personnel can utilize the interactive PX1 reconstitution calculator to ensure accurate dilution modeling prior to fluid handling.
Once solubilized in aqueous media, $NAD^+$ becomes vulnerable to hydrolytic cleavage of the pyrophosphate bond and enzymatic degradation from environmental nucleases. Consequently, master stock solutions should not be subjected to repeated freeze-thaw cycles, which accelerate physical degradation and alter localized solute concentrations.
To maximize analytical consistency, the reconstituted 10mg solution should be immediately divided into single-use micro-aliquots using pre-chilled, sterile polypropylene microcentrifuge tubes. For example, a 10mg vial reconstituted in 2.0 mL of buffer can be dispensed into twenty 100 µL aliquots (containing 500 µg of compound each). Each aliquot should be tightly sealed, labeled with the lot number and reconstitution date, and immediately transferred to deep-freeze storage. When preparing experimental plates, individual aliquots should be thawed on ice and used immediately in working buffer solutions.
Storage requirements for research-grade $NAD^+$ depend directly on the physical state of the compound and the intended duration of storage:
1. Lyophilized Powder (Unopened Vial): Dry $NAD^+$ powder exhibits high thermal stability when stored in a desiccated environment at -20°C. Under these conditions, the compound remains stable for up to 24 months. For ultra-long-term archiving, storage at -80°C is recommended to prevent ambient moisture absorption.
2. Reconstituted Aqueous Stock Solutions: Solubilized $NAD^+$ is stable at 2°C to 8°C for no longer than 24 to 48 hours. For long-term preservation of aqueous stocks, aliquots must be maintained at -80°C, where degradation remains under 1% per month. Reconstituted solutions must be protected from direct light exposure using foil or amber storage containers, as UV light promotes degradation of the nicotinamide ring structure.
To ensure reproducible data across in vitro and animal models, every batch of $NAD^+$ produced for PX1 Research undergoes strict analytical verification. Every shipped vial is tied to a lot-matched Certificate of Analysis (COA) issued by an independent ISO 17025 accredited testing facility.
Primary quality parameters verified on the COA include:
• Purity Determination via HPLC: High-Performance Liquid Chromatography (HPLC) with UV detection at 260 nm confirms compound purity exceeds 98.0% peak area, ensuring the absence of degradation products such as free nicotinamide or ADP-ribose.
• Identity Confirmation via ESI-MS: Electrospray Ionization Mass Spectrometry verifies the molecular weight ([M-H]⁻ ion peak at m/z 662.4) against theoretical chemical structures.
• Endotoxin Quantitation: Limulus Amebocyte Lysate (LAL) testing certifies endotoxin levels remain below strict threshold limits (<0.05 EU/mg), making the compound suitable for sensitive cellular assays.
Researchers can review and download full documentation for their specific order lot at any time via the PX1 COA lookup portal.
Determining whether to purchase a 10mg vial or transition to larger bulk quantities depends on the scale, design, and frequency of your research protocols. The 10mg fill size provides distinct logistical advantages for low-throughput screening, exploratory pilot studies, or assays requiring freshly prepared reagents to prevent batch variance.
Conversely, laboratories conducting large-scale longitudinal rodent studies, high-throughput enzymatic screens, or continuous cell culture passages often consume several hundred milligrams of compound per month. In these scenarios, utilizing multiple 10mg vials increases packaging waste and volumetric handling steps. For high-volume research operations, sourcing higher mass allocations or establishing a high-volume supply agreement via our /wholesale portal provides enhanced cost efficiencies and lot uniformity across extended experimental timelines.
Within metabolic, strength, and mitochondrial bioenergetics research, investigators frequently evaluate $NAD^+$ alongside related coenzymes and signaling peptides to map cellular respiratory pathways. While direct administration of $NAD^+$ tests extracellular signaling and direct enzymatic cleavage in cell culture assays, precursor molecules like NMN (Nicotinamide Mononucleotide) are widely utilized in preclinical models to study intracellular biosynthetic pathways via the salvage pathway. Concurrently, mitochondrial-derived peptides such as MOTS-c and targeted mitochondrial-targeting compounds like SS-31 are investigated for their roles in metabolic homeostasis, ATP production, and stress resistance. Comparing these distinct classes in parallel in vitro models allows researchers to isolate specific mechanisms governing nuclear-mitochondrial communication and cellular bioenergetics.
PX1 Research is dedicated to supporting academic, biotechnology, and institutional research facilities across the United States. All research compounds are synthesized in state-of-the-art, GMP-compliant facilities and undergo thorough quality control before distribution.
Orders placed before 3:00 PM EST Monday through Friday are dispatched same-day from our dual distribution hubs located in California and Arizona. This dual-hub architecture minimizes transit times, ensuring that temperature-sensitive, lyophilized research materials arrive intact and ready for immediate laboratory processing. Explore our deep analytical database and protocol guides through the central PX1 research hub.
What is the concentration of a 10mg NAD+ vial reconstituted in 2mL of sterile water?
Reconstituting a 10mg NAD+ vial with 2.0 mL of diluent produces a solution concentration of 5.0 mg/mL (approx. 7.54 mM).
How should reconstituted NAD+ solutions be stored to maintain chemical stability?
Reconstituted NAD+ should be divided into single-use aliquots and stored at -80°C to prevent hydrolysis. Avoid repeated freeze-thaw cycles and shield stock solutions from light.
Where can I download the lot-matched COA for my NAD+ order?
Lot-matched Certificates of Analysis showing HPLC purity and mass spectrometry verification can be accessed directly on the PX1 COA lookup page using your batch lot number.
Is the 10mg NAD+ vial format intended for human or animal administration?
No. All products supplied by PX1 Research, including NAD+ 10mg vials, are strictly for laboratory research use only (in vitro and preclinical studies). They are not for human, clinical, or veterinary applications.
What diluents are recommended for reconstituting NAD+ for cell culture assays?
Commonly used diluents include sterile nuclease-free water, sterile bacteriostatic water, or sterile phosphate-buffered saline (PBS, pH 7.4), depending on assay compatibility.
What are the primary purity thresholds for PX1 NAD+ research vials?
PX1 Research mandates an HPLC purity threshold of ≥98.0%, verified molecular weight via ESI-MS, and endotoxin levels tested under <0.05 EU/mg.
Does PX1 offer larger quantity sizes if 10mg is insufficient for my protocol?
Yes. If 10mg is insufficient or currently unlisted, PX1 provides larger format options and multi-vial options accessible via our main catalog or wholesale department.
Why is protection from ambient light necessary for NAD+ stocks?
Pyridine nucleotides like NAD+ can undergo slow photochemical degradation under ambient UV light, altering compound purity and generating interfering breakdown products.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.